TLDR:
- mPATH Health, a digital health company focused on improving cancer screening, raised $1.1M in funding.
- The funding round included angel investments and a National Cancer Institute grant.
mPATH Health, a digital health company based in Winston-Salem, NC, recently secured $1.1M in funding. This funding round consisted of $706K in angel investments and $400K from a competitive National Cancer Institute Small Business Technology Transfer Grant. Key investors in this round included Atlanta Technology Angels, FCP Ventures, First Launch Capital, RTP Angel Fund, and VentureSouth. The company plans to use this capital to develop new modules for other preventive care needs, incorporate artificial intelligence into their outreach efforts, and accelerate their growth trajectory. Led by CEO and Founder Dr. Dave Miller, mPATH Health is dedicated to enhancing preventive cancer screening by leveraging automation and behavioral science. The company’s platform uses plain language, engaging animations, and video testimonials to educate, motivate, and empower individuals to seek and complete evidence-based recommended screenings. Currently, mPATH is being utilized in three healthcare systems in North Carolina for colorectal cancer and lung cancer screening, with a fourth major healthcare system set to adopt the program in March.
This latest funding round is a significant milestone for mPATH Health, as it not only provides the necessary capital to further develop their platform and expand their services, but also validates the importance and potential impact of their work in improving cancer screening rates. With the support of key investors and the backing of a prestigious grant from the National Cancer Institute, mPATH Health is well-positioned to continue making strides in the realm of preventive care and cancer screening.
